# Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations

_Canadian Journal of Urology · Jeanny B. Aragon-Ching, Ravi A. Madan · 2026_

Canonical: https://diginpl.com/books/paper-cju-2026-082958
Last updated: 2026-10-02

## Quick facts

- **Author:** Jeanny B. Aragon-Ching; Ravi A. Madan ([Crossref](https://doi.org/10.32604/cju.2026.082958))
- **Published:** 2026 ([Crossref](https://doi.org/10.32604/cju.2026.082958))
- **Publisher:** Tech Science Press ([Crossref](https://doi.org/10.32604/cju.2026.082958))
- **Journal:** Canadian Journal of Urology ([Crossref](https://doi.org/10.32604/cju.2026.082958))
- **DOI:** 10.32604/cju.2026.082958 ([Crossref](https://doi.org/10.32604/cju.2026.082958))

## Questions

**Who wrote Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations?**  
Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations was written by Jeanny B. Aragon-Ching, Ravi A. Madan.

**When was Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations first published?**  
Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations was first published in 2026.

## Sources

- [Publisher record (DOI, via Crossref)](https://doi.org/10.32604/cju.2026.082958)

## Licence and attribution

Open-access publication. Read it free at the publisher: https://doi.org/10.32604/cju.2026.082958.

## Cite this page

"Highlighting the NCI’s working group on biochemically recurrent prostate cancer for clinical trial considerations". DigiNepal. Last updated 2 October 2026. https://diginpl.com/books/paper-cju-2026-082958. Retrieved 14 November 2026.